Skip to main content
Account

Peer review reports

From: Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy

Original Submission
9 Apr 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
3 May 2024 Reviewed Reviewer Report
22 May 2024 Reviewed Reviewer Report
5 Jun 2024 Author responded Author comments - Ify R Mordi
Resubmission - Version 3
5 Jun 2024 Submitted Manuscript version 3
9 Jun 2024 Reviewed Reviewer Report
28 Jun 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Jun 2024 Editorially accepted
12 Jul 2024 Article published 10.1186/s12872-024-04022-7

Learn about peer review

Back to article page

Navigation